Pharmacology, Toxicology and Pharmaceutical Science
Sparteine
100%
Pharmacokinetics
78%
CYP2D6
65%
Imipramine
59%
Cytochrome P450
44%
Metformin
38%
CYP2C19
36%
Fluvoxamine
36%
Mephenytoin
35%
Selective Serotonin Reuptake Inhibitor
32%
Paroxetine
32%
Normal Human
32%
CYP3A4
30%
Debrisoquine
30%
Desipramine
29%
Quinidine
29%
CYP1A2
28%
Morphine
26%
Pharmacogenetics
25%
Placebo
24%
Codeine
22%
Tramadol
19%
Citalopram
19%
Proguanil
19%
Adverse Drug Reaction
18%
Paclitaxel
17%
Cytochrome
16%
High Performance Liquid Chromatography
16%
Isoenzyme
16%
Fluoxetine
16%
Diabetic Neuropathy
15%
Clomipramine
15%
Theophylline
15%
Drug-Drug Interaction
14%
CYP2C8
13%
Analgesic Agent
12%
Elimination
12%
Oxycodone
11%
Experimental Pain
11%
Ovary Cancer
11%
Drug Interaction
9%
Cycloguanil
9%
Pharmacodynamics
8%
Polyneuropathy
8%
Clopidogrel
8%
Escitalopram
8%
Pharmacogenomics
8%
Dicloxacillin
8%
Seproxetine
8%
Tricyclic Antidepressant
8%
Neuroscience
Sparteine
39%
Cytochrome P450 2D6
29%
Imipramine
27%
Cytochrome P450 2C19
23%
Placebo
19%
Debrisoquine
18%
Blood Plasma
17%
Mephenytoin
17%
Metabolic Pathway
17%
Pharmacokinetics
16%
Paroxetine
14%
Clomipramine
14%
Tramadol
14%
Desipramine
12%
Metformin
11%
Escitalopram
11%
Diabetic Neuropathy
11%
Selective Serotonin Reuptake Inhibitor
10%
Nortriptyline
8%
Morphine
8%
Cytochrome P450
7%
Citalopram
7%
Pain Threshold
7%
Polyneuropathy
6%
Crossover Study
6%
Oxycodone
5%
Cytochrome P450 2C8
5%
Serotonergic
5%
Meta-Analysis
5%
Tricyclic Antidepressant
5%
Proguanil
5%
Genetic Polymorphism
5%
Biochemistry, Genetics and Molecular Biology
Pharmacokinetics
34%
CYP2D6
26%
Cytochrome P450
25%
Genotyping
23%
Allele
22%
Sparteine
20%
CYP2C19
19%
Metabolic Pathway
16%
Pharmacogenetics
14%
Blood Level
11%
Genetics
11%
Genetic Polymorphism
10%
Genetic Divergence
10%
Steady State
10%
Normal Human
8%
Isozyme
7%
Drug Interaction
7%
Blood Plasma
7%
Enzyme
7%
Single-Nucleotide Polymorphism
6%
Gluconeogenesis
6%
Drug Oxidation
5%
CYP1A2
5%
Concentration at Steady-State
5%
Glucose Metabolism
5%
